Condition (MeSH)
Endometrial Stromal Tumors
ClinicalTrials.gov lists 27 trials for Endometrial Stromal Tumors or a narrower condition beneath it. European Organisation for Research and Treatment of Cancer - EORTC has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 27 trials are tagged with Endometrial Stromal Tumors itself; the rest are tagged with a narrower condition beneath it.
When did Endometrial Stromal Tumors trials start? (20)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 3
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2019 | 2 |
| 2017 | 1 |
| 2016 | 1 |
| 2014 | 1 |
| 2011 | 1 |
| 2010 | 1 |
Showing 10 of 20 earlier years.
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Endometrial Stromal Tumors trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 18 |
| Phase 3 | 4 |
| Observational | 3 |
How many Endometrial Stromal Tumors trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 19 |
| Terminated | 2 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Endometrial Stromal Tumors trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| Gynecologic Oncology Group | 3 |
| Novartis Pharmaceuticals | 2 |
| HRYZ Biotech Co. | 1 |
| Italian Sarcoma Group | 1 |
Showing 5 of 6 sponsors.
Which drugs are being tested for Endometrial Stromal Tumors? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Imatinib | 2 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Ifosfamid | 3 |
| Doxorubicine | 3 |
| Pegylated Liposomal Doxorubicin (PLD), Doxil | 2 |
| Filgrastime (G-CSF) | 2 |
| Radiation Therapy | 2 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Endometrial Stromal Tumors trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Abdominal Pain | 4 | 1 |
| Adrenal Adenoma | 3 | 1 |
| Death Nos | 3 | 1 |
| Anemia | 2 | 1 |
| Death not associated with CTCAE term-Disease progression NOS | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Endometrial Stromal Tumors? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. | Journal of clinical pathology | 2015 | Yes |
| Malignant potential of endometrial stromal tumor with limited infiltration: a case report. | International journal of surgical pathology | 2014 | Yes |
| Endometrial stromal tumors: the new WHO classification. | Advances in anatomic pathology | 2014 | Yes |
| The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus. | Annals of surgical oncology | 2011 | Yes |
| Findings to date from the ASCUS-LSIL Triage Study (ALTS). | Archives of pathology & laboratory medicine | 2003 | Yes |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.